Host Genetic Factors Affect Susceptibility to Norovirus Infections in Burkina Faso

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Nordgren, Johan ^a   Nitiema, Léon W ^b   Ouermi, Djeneba ^b   Simpore, Jacques ^b   Svensson, Lennart ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP LEWIS SYSTEM; BLOOD GROUP O; BURKINA FASO; CHILD; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NOROVIRUS; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SEASONAL VARIATION; VIRUS DETECTION; VIRUS STRAIN;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BLOOD GROUP ANTIGENS; BURKINA FASO; CALICIVIRIDAE INFECTIONS; CHILD; CHILD, PRESCHOOL; DIARRHEA; FEMALE; GASTROENTERITIS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INFANT, NEWBORN; LEWIS BLOOD-GROUP SYSTEM; MALE; MOLECULAR SEQUENCE DATA; NOROVIRUS; PHENOTYPE; PHYLOGENY; VIRAL NONSTRUCTURAL PROTEINS; YOUNG ADULT;

EID: 84880475223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069557     Document Type: Article

References (53)

1. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, et al. (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14: 1224-1231.
2. Bucardo F, Lindgren PE, Svensson L, Nordgren J, (2011) Low prevalence of rotavirus and high prevalence of norovirus in hospital and community wastewater after introduction of rotavirus vaccine in Nicaragua. PLoS One 6: e25962.
3. Puustinen L, Blazevic V, Salminen M, Hamalainen M, Rasanen S, et al. (2011) Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010. Scand J Infect Dis 43: 804-808.
4. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, et al. (2006) Norovirus classification and proposed strain nomenclature. Virology 346: 312-323.
5. Wang QH, Han MG, Cheetham S, Souza M, Funk JA, et al. (2005) Porcine noroviruses related to human noroviruses. Emerg Infect Dis 11: 1874-1881.
6. Mesquita JR, Barclay L, Nascimento MS, Vinje J, (2010) Novel norovirus in dogs with diarrhea. Emerg Infect Dis 16: 980-982.
7. Bucardo F, Nordgren J, Carlsson B, Paniagua M, Lindgren PE, et al. (2008) Pediatric norovirus diarrhea in Nicaragua. J Clin Microbiol 46: 2573-2580.
8. Siebenga JJ, Vennema H, Zheng DP, Vinje J, Lee BE, et al. (2009) Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis 200: 802-812.
9. Bucardo F, Nordgren J, Carlsson B, Kindberg E, Paniagua M, et al. (2010) Asymptomatic norovirus infections in Nicaraguan children and its association with viral properties and histo-blood group antigens. Pediatr Infect Dis J 29: 934-939.
10. Desai R, Hembree CD, Handel A, Matthews JE, Dickey BW, et al. (2012) Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: A systematic literature review. Clin Infect Dis 55: 189-193.
11. Ayukekbong J, Lindh M, Nenonen N, Tah F, Nkuo-Akenji T, et al. (2011) Enteric viruses in healthy children in Cameroon: viral load and genotyping of norovirus strains. J Med Virol 83: 2135-2142.
12. Mans J, de Villiers JC, du Plessis NM, Avenant T, Taylor MB, (2010) Emerging norovirus GII.4 2008 variant detected in hospitalised paediatric patients in South Africa. J Clin Virol 49: 258-264.
13. Mattison K, Sebunya TK, Shukla A, Noliwe LN, Bidawid S, (2010) Molecular detection and characterization of noroviruses from children in Botswana. J Med Virol 82: 321-324.
14. Dove W, Cunliffe NA, Gondwe JS, Broadhead RL, Molyneux ME, et al. (2005) Detection and characterization of human caliciviruses in hospitalized children with acute gastroenteritis in Blantyre, Malawi. J Med Virol 77: 522-527.
15. Armah GE, Gallimore CI, Binka FN, Asmah RH, Green J, et al. (2006) Characterisation of norovirus strains in rural Ghanaian children with acute diarrhoea. J Med Virol 78: 1480-1485.
16. Kindberg E, Akerlind B, Johnsen C, Knudsen JD, Heltberg O, et al. (2007) Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol 45: 2720-2722.
17. Nordgren J, Kindberg E, Lindgren PE, Matussek A, Svensson L, (2010) Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. Emerg Infect Dis 16: 81-87.
18. Tan M, Jin M, Xie H, Duan Z, Jiang X, et al. (2008) Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 80: 1296-1301.
19. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, et al. (2003) Human susceptibility and resistance to Norwalk virus infection. Nat Med 9: 548-553.
20. Thorven M, Grahn A, Hedlund KO, Johansson H, Wahlfrid C, et al. (2005) A homozygous nonsense mutation (428G->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 79: 15351-15355.
21. Rydell GE, Kindberg E, Larson G, Svensson L, (2011) Susceptibility to winter vomiting disease: a sweet matter. Rev Med Virol 21: 370-382.
22. Shirato H, Ogawa S, Ito H, Sato T, Kameyama A, et al. (2008) Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol 82: 10756-10767.
23. Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, et al. (2005) Cellular and humoral immunity following Snow Mountain virus challenge. J Virol 79: 2900-2909.
24. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP, (2005) Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191: 749-754.
25. Carlsson B, Kindberg E, Buesa J, Rydell GE, Lidon MF, et al. (2009) The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One 4: e5593.
26. Soejima M, Munkhtulga L, Iwamoto S, Koda Y, (2009) Genetic variation of FUT3 in Ghanaians, Caucasians, and Mongolians. Transfusion 49: 959-966.
27. Nordgren J, Nitiema LW, Sharma S, Ouermi D, Traore AS, et al. (2012) Emergence of Unusual G6P[6] Rotaviruses in Children, Burkina Faso, 2009-2010. Emerg Infect Dis 18: 589-597.
28. Nitiema LW, Nordgren J, Ouermi D, Dianou D, Traore AS, et al. (2011) Burden of rotavirus and other enteropathogens among children with diarrhea in Burkina Faso. Int J Infect Dis 15: e646-652.
29. Wardlaw T, Salama P, Brocklehurst C, Chopra M, Mason E, (2010) Diarrhoea: why children are still dying and what can be done. Lancet 375: 870-872.
30. Rydell GE, Nilsson J, Rodriguez-Diaz J, Ruvoen-Clouet N, Svensson L, et al. (2009) Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology 19: 309-320.
31. Kageyama T, Kojima S, Shinohara M, Uchida K, Fukushi S, et al. (2003) Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 41: 1548-1557.
32. Nordgren J, Bucardo F, Dienus O, Svensson L, Lindgren PE, (2008) Novel light-upon-extension real-time PCR assays for detection and quantification of genogroup I and II noroviruses in clinical specimens. J Clin Microbiol 46: 164-170.
33. Japhet MO, Adesina OA, Famurewa O, Svensson L, Nordgren J, (2012) Molecular Epidemiology of Rotavirus and Norovirus in Ile-Ife, Nigeria: High Prevalence of G12P[8] Rotavirus Strains and Detection of a Rare Norovirus Genotype. J Med Virol 84: 1489-1496.
34. Khamrin P, Maneekarn N, Peerakome S, Tonusin S, Malasao R, et al. (2007) Genetic diversity of noroviruses and sapoviruses in children hospitalized with acute gastroenteritis in Chiang Mai, Thailand. J Med Virol 79: 1921-1926.
35. Sanchez-Fauquier A, Montero V, Moreno S, Sole M, Colomina J, et al. (2006) Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain. Emerg Infect Dis 12: 1536-1541.
36. Monica B, Ramani S, Banerjee I, Primrose B, Iturriza-Gomara M, et al. (2007) Human caliciviruses in symptomatic and asymptomatic infections in children in Vellore, South India. J Med Virol 79: 544-551.
37. Kroneman A, Verhoef L, Harris J, Vennema H, Duizer E, et al. (2008) Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol 46: 2959-2965.
38. Tran A, Talmud D, Lejeune B, Jovenin N, Renois F, et al. (2010) Prevalence of rotavirus, adenovirus, norovirus, and astrovirus infections and coinfections among hospitalized children in northern France. J Clin Microbiol 48: 1943-1946.
39. Abugalia M, Cuevas L, Kirby A, Dove W, Nakagomi O, et al. (2011) Clinical features and molecular epidemiology of rotavirus and norovirus infections in Libyan children. J Med Virol 83: 1849-1856.
40. Koda Y, Soejima M, Kimura H, (2001) The polymorphisms of fucosyltransferases. Leg Med (Tokyo) 3: 2-14.
41. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS, (2010) Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol 8: 231-241.
42. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, et al. (2008) Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 5: e31.
43. Larsson MM, Rydell GE, Grahn A, Rodriguez-Diaz J, Akerlind B, et al. (2006) Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis 194: 1422-1427.
44. Bucardo F, Kindberg E, Paniagua M, Grahn A, Larson G, et al. (2009) Genetic susceptibility to symptomatic norovirus infection in Nicaragua. J Med Virol 81: 728-735.
45. Corvelo TCO, Aguiar DCF, Sagica FES, (2002) The expression of ABH and Lewis antigens in Brazilian semi-isolated Black communities. Genet Mol Biol 25: 259-263.
46. de Rougemont A, Ruvoen-Clouet N, Simon B, Estienney M, Elie-Caille C, et al. (2011) Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J Virol 85: 4057-4070.
47. Nasir W, Frank M, Koppisetty CA, Larson G, Nyholm PG, (2012) Lewis histo-blood group alpha1,3/alpha1,4 fucose residues may both mediate binding to GII.4 noroviruses. Glycobiology 22: 1163-1172.
48. Jin M, He Y, Li H, Huang P, Zhong W, et al. (2013) Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes. PLoS One 8: e58605.
49. Huang P, Farkas T, Zhong W, Tan M, Thornton S, et al. (2005) Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79: 6714-6722.
50. Kindberg E, Svensson L, (2009) Genetic basis of host resistance to norovirus infection. Future virology 4: 369-382.
51. Hutson AM, Atmar RL, Graham DY, Estes MK, (2002) Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185: 1335-1337.
52. Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, et al. (2012) Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 30: 3580-3586.
53. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, et al. (2011) Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 365: 2178-2187.